Cargando…

A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques

Detalles Bibliográficos
Autores principales:	Jensen, K, Ranganathan, UD, Kozlowski, P, Van Rompay, K, Canfield, D, Ravindran, R, Khan, I, Luciw, P, Fennelly, G, Larsen, M, Abel, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441880/ http://dx.doi.org/10.1186/1742-4690-9-S2-O4

Ejemplares similares

SIV Evolutionary Dynamics in Cynomolgus Macaques during SIV-Mycobacterium tuberculosis Co-Infection
por: Tisthammer, Kaho H., et al.
Publicado: (2021)

P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
por: Valentin, A, et al.
Publicado: (2009)

SIV Infection Facilitates Mycobacterium tuberculosis Infection of Rhesus Macaques
por: Guo, Ming, et al.
Publicado: (2017)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
por: Bourry, Olivier, et al.
Publicado: (2009)

OA07-03. Influence of preexisting vaccinia immunity on a DNA/MVA SIV vaccine, decreased cellular immunity but enhanced control of a pathogenic SIV challenge
por: Kannanganat, S, et al.
Publicado: (2009)

Hippocampal Neuronal Loss in Infant Macaques Orally Infected with Virulent Simian Immunodeficiency Virus (SIV)
por: Carryl, Heather, et al.
Publicado: (2017)

Recombinant attenuated M.tuberculosis-SIVgag(rAMtb-gag) vaccination primes for SIV-specific CD8 T cell response that are boosted by Ad5-SIVgag in mice
por: Kadayam Ranganathan, U, et al.
Publicado: (2012)

Lv4, an activity that restricts nuclear entry of SIV(MAC)/SIV(SM) in human blood cells
por: Pizzato, Massimo, et al.
Publicado: (2013)

Host Immunity to Mycobacterium tuberculosis Infection Is Similar in Simian Immunodeficiency Virus (SIV)-Infected, Antiretroviral Therapy-Treated and SIV-Naïve Juvenile Macaques
por: Larson, Erica C., et al.
Publicado: (2023)

Suppression of SIV-specific CD4(+) T cells by infant but not adult macaque regulatory T cells: implications for SIV disease progression
por: Hartigan-O'Connor, Dennis J., et al.
Publicado: (2007)

Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection
por: Hao, Xing Pei, et al.
Publicado: (2015)

SIVΔnef vaccination mobilizes systemic and mucosal natural killer cells in Mamu A*01+ macaques
por: Reeves, R, et al.
Publicado: (2012)

Acute infection by SIV: massive immunological damage
por: Roederer, Mario
Publicado: (2006)

Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
por: Hamimi, C, et al.
Publicado: (2012)

Preservation of a subset of SIV-specific central memory CD4+ T cells correlates with control of viremia in SIVmac251 infected macaques
por: Felber, Barbara K, et al.
Publicado: (2006)

Antibody glycosylation correlates with disease progression in SIV‐ Mycobacterium tuberculosis coinfected cynomolgus macaques
por: Haycroft, Ebene R, et al.
Publicado: (2023)

Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques
por: Roberts, Emily R., et al.
Publicado: (2016)

Reduced neuronal population in the dorsolateral prefrontal cortex in infant macaques infected with simian immunodeficiency virus (SIV)
por: Haddad, Alexandra, et al.
Publicado: (2021)

Tetherin antagonism by HIV-1 and its SIV precursors
por: Kirchhoff, Frank
Publicado: (2011)

Increased neutrophil apoptosis in chronically SIV-infected macaques
por: Elbim, Carole, et al.
Publicado: (2009)

MHC and KIR Polymorphisms in Rhesus Macaque SIV Infection
por: Walter, Lutz, et al.
Publicado: (2015)

Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
por: Boopathy, Archana V., et al.
Publicado: (2023)

Protection of Macaques with Diverse MHC Genotypes against a Heterologous SIV by Vaccination with a Deglycosylated Live-Attenuated SIV
por: Sugimoto, Chie, et al.
Publicado: (2010)

Transduction of SIV-Specific TCR Genes into Rhesus Macaque CD8(+) T Cells Conveys the Ability to Suppress SIV Replication
por: Barsov, Eugene V., et al.
Publicado: (2011)

Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
por: Zhang, X, et al.
Publicado: (2012)

Characterization of Nef expression in different brain regions of SIV-infected macaques
por: Yarandi, Shadan S., et al.
Publicado: (2020)

Significant protection from infection and AIDS progression after gastrointestinal and oral vaccinations, respectively, with a SIV DNA/rMVA vaccine
por: Aldovini, A, et al.
Publicado: (2012)

P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
por: Stambas, J, et al.
Publicado: (2009)

Macaques vaccinated with live-attenuated SIV control replication of heterologous virus
por: Reynolds, Matthew R., et al.
Publicado: (2008)

IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
por: Garibal, Julie, et al.
Publicado: (2012)

Hypothetical endogenous SIV-like antigens in Mauritian cynomolgus macaques
por: Li, Hongzhao, et al.
Publicado: (2018)

Rhesus macaque IFITM3 gene polymorphisms and SIV infection
por: Winkler, Michael, et al.
Publicado: (2017)

Cynomolgus macaque IL37 polymorphism and control of SIV infection
por: Shiina, Takashi, et al.
Publicado: (2019)

Early Emergence and Selection of a SIV-LTR C/EBP Site Variant in SIV-Infected Macaques That Increases Virus Infectivity
por: Ravimohan, Shruthi, et al.
Publicado: (2012)

Correction: Transduction of SIV-Specific TCR Genes into Rhesus Macaque CD8(+) T Cells Conveys the Ability to Suppress SIV Replication
por: Barsov, Eugene V., et al.
Publicado: (2018)

Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal
por: Van Rompay, Koen K A, et al.
Publicado: (2012)

Early pro-inflammatory host response to recombinant HSV-SIV vaccination in sooty mangabeys
por: Rout, N, et al.
Publicado: (2012)

Understanding the benign nature of natural SIV infection: Implications for AIDS pathogenesis
por: Silvestri, Guido
Publicado: (2006)

GCM-SIV1.5: Optimal Tradeoff between GCM-SIV1 and GCM-SIV2
por: Zhang, Ping
Publicado: (2023)

RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues
por: Liyanage, NP, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bvlp4qv4mpreubk6dre55hekoj